These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11011745)

  • 1. Red marrow dosimetry for radiolabeled antibodies that bind to marrow, bone, or blood components.
    Sgouros G; Stabin M; Erdi Y; Akabani G; Kwok C; Brill AB; Wessels B
    Med Phys; 2000 Sep; 27(9):2150-64. PubMed ID: 11011745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Monte Carlo simulations with a realistic rat phantom for examining the correlation between hematopoietic system response and red marrow absorbed dose in Brown Norway rats undergoing radionuclide therapy with (177)Lu- and (90)Y-BR96 mAbs.
    Larsson E; Ljungberg M; Martensson L; Nilsson R; Tennvall J; Strand SE; Jonsson BA
    Med Phys; 2012 Jul; 39(7):4434-43. PubMed ID: 22830776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal dosimetry in a voxel-based rat phantom for internal exposures to photons and electrons.
    Xie T; Han D; Liu Y; Sun W; Liu Q
    Med Phys; 2010 May; 37(5):2167-78. PubMed ID: 20527551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel size effects in three-dimensional nuclear magnetic resonance microscopy performed for trabecular bone dosimetry.
    Rajon DA; Jokisch DW; Patton PW; Shah AP; Bolch WE
    Med Phys; 2000 Nov; 27(11):2624-35. PubMed ID: 11128316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a clinically meaningful predictive model of hematologic toxicity in nonmyeloablative targeted radiotherapy: practical aspects and limitations of red marrow dosimetry.
    Siegel JA
    Cancer Biother Radiopharm; 2005 Apr; 20(2):126-40. PubMed ID: 15869446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings.
    Behr TM; Béhé M; Sgouros G
    Cancer Biother Radiopharm; 2002 Aug; 17(4):445-64. PubMed ID: 12396708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
    Hindorf C; Lindén O; Tennvall J; Wingårdh K; Strand SE
    Acta Oncol; 2005; 44(6):579-88. PubMed ID: 16165917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for the inclusion of shallow marrow and adipose tissue in pathlength-based skeletal dosimetry.
    Jokisch DW; Rajon DA; Patton PW; Bolch WE
    Phys Med Biol; 2011 May; 56(9):2699-713. PubMed ID: 21464530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
    DeNardo GL; Siantar CL; DeNardo SJ
    Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of bone marrow and bone endosteum dosimetry methods for photon sources.
    Lee C; Lee C; Shah AP; Bolch WE
    Phys Med Biol; 2006 Nov; 51(21):5391-407. PubMed ID: 17047259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
    Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
    J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dosimetry of bone incorporating alpha-emitting radionuclides.
    Montelius A; Burlin TE
    Br J Radiol; 1984 Jul; 57(679):609-16. PubMed ID: 6733407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male.
    Watchman CJ; Jokisch DW; Patton PW; Rajon DA; Sgouros G; Bolch WE
    J Nucl Med; 2005 Jul; 46(7):1171-85. PubMed ID: 16000287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An image-based skeletal dosimetry model for the ICRP reference adult male--internal electron sources.
    Hough M; Johnson P; Rajon D; Jokisch D; Lee C; Bolch W
    Phys Med Biol; 2011 Apr; 56(8):2309-46. PubMed ID: 21427487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry.
    Hindorf C; Glatting G; Chiesa C; Lindén O; Flux G;
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1238-50. PubMed ID: 20411259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry.
    Baechler S; Hobbs RF; Prideaux AR; Wahl RL; Sgouros G
    Med Phys; 2008 Mar; 35(3):1123-34. PubMed ID: 18404947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations of marrow cellularity in 3-dimensional dosimetric models of the trabecular skeleton.
    Bolch WE; Patton PW; Rajon DA; Shah AP; Jokisch DW; Inglis BA
    J Nucl Med; 2002 Jan; 43(1):97-108. PubMed ID: 11801712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.